We sought to further evaluate the therapeutic potential of RLN2-secreting CAR-T cells in models that more closely recapitulate the stromal-rich tumor microenvironment encountered in human pancreatic cancer. The gene discussed is RLN2; the disease is familial pancreatic carcinoma.